- call +1-201-465-4211
- email sales@mrinsights.biz
The immune system is an assembly of structures and processes inside the body to protect against possibly damaging foreign bodies and diseases. It identifies various threats like bacteria, viruses, and parasites and distinguishes them from body's healthy tissues. When the immune system weakness and lose the capability to detect and destroy the abnormal cells or body attacks and damages its tissues lead to diseases like cancer and autoimmune diseases. Immunotherapy is a process which includes the treatment by inducing, enhancing or suppressing an immune system to fight against the diseases.
Scope of the Report:
The worldwide market for Immunology Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Immunology Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Abbott Laboratories
Active Biotech
Eli Lilly and Company
Autoimmune Inc.
Pfizer
GlaxoSmithKline plc
Seattle Genetics
Genentech
F. Hoffmann-La Roche Ltd.
Eisai Co.
Bayer AG
Sanofi Aventis LLC.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Monoclonal Antibodies (mAb)
Antibody Drug Conjugates
Interferon and Cytokine therapies
Immunosuppressive medication
Market Segment by Applications, can be divided into
Hospitals
Clinics
Cancer Research Centers and Institutes
There are 15 Chapters to deeply display the global Immunology Drug market.
Chapter 1, to describe Immunology Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Immunology Drug, with sales, revenue, and price of Immunology Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Immunology Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Immunology Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Immunology Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Immunology Drug Introduction
1.2 Market Analysis by Type
1.2.1 Monoclonal Antibodies (mAb)
1.2.2 Antibody Drug Conjugates
1.2.3 Interferon and Cytokine therapies
1.2.4 Immunosuppressive medication
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Cancer Research Centers and Institutes
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Immunology Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Active Biotech
2.2.1 Business Overview
2.2.2 Immunology Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Active Biotech Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Eli Lilly and Company
2.3.1 Business Overview
2.3.2 Immunology Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eli Lilly and Company Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Autoimmune Inc.
2.4.1 Business Overview
2.4.2 Immunology Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Autoimmune Inc. Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Immunology Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 GlaxoSmithKline plc
2.6.1 Business Overview
2.6.2 Immunology Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GlaxoSmithKline plc Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Seattle Genetics
2.7.1 Business Overview
2.7.2 Immunology Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Seattle Genetics Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Genentech
2.8.1 Business Overview
2.8.2 Immunology Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Genentech Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 F. Hoffmann-La Roche Ltd.
2.9.1 Business Overview
2.9.2 Immunology Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 F. Hoffmann-La Roche Ltd. Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Eisai Co.
2.10.1 Business Overview
2.10.2 Immunology Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Eisai Co. Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Bayer AG
2.11.1 Business Overview
2.11.2 Immunology Drug Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Bayer AG Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Sanofi Aventis LLC.
2.12.1 Business Overview
2.12.2 Immunology Drug Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Sanofi Aventis LLC. Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Immunology Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Immunology Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Immunology Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Immunology Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Immunology Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Immunology Drug Market Analysis by Regions
4.1 Global Immunology Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Immunology Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Immunology Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Immunology Drug Sales and Growth Rate (2013-2018)
4.3 Europe Immunology Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Immunology Drug Sales and Growth Rate (2013-2018)
4.5 South America Immunology Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Immunology Drug Sales and Growth Rate (2013-2018)
5 North America Immunology Drug by Countries
5.1 North America Immunology Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Immunology Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Immunology Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Immunology Drug Sales and Growth Rate (2013-2018)
5.3 Canada Immunology Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Immunology Drug Sales and Growth Rate (2013-2018)
6 Europe Immunology Drug by Countries
6.1 Europe Immunology Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Immunology Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Immunology Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Immunology Drug Sales and Growth Rate (2013-2018)
6.3 UK Immunology Drug Sales and Growth Rate (2013-2018)
6.4 France Immunology Drug Sales and Growth Rate (2013-2018)
6.5 Russia Immunology Drug Sales and Growth Rate (2013-2018)
6.6 Italy Immunology Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Immunology Drug by Countries
7.1 Asia-Pacific Immunology Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Immunology Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Immunology Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Immunology Drug Sales and Growth Rate (2013-2018)
7.3 Japan Immunology Drug Sales and Growth Rate (2013-2018)
7.4 Korea Immunology Drug Sales and Growth Rate (2013-2018)
7.5 India Immunology Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Immunology Drug Sales and Growth Rate (2013-2018)
8 South America Immunology Drug by Countries
8.1 South America Immunology Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Immunology Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Immunology Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Immunology Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Immunology Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Immunology Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Immunology Drug by Countries
9.1 Middle East and Africa Immunology Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Immunology Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Immunology Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Immunology Drug Sales and Growth Rate (2013-2018)
9.3 UAE Immunology Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Immunology Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Immunology Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Immunology Drug Sales and Growth Rate (2013-2018)
10 Global Immunology Drug Market Segment by Type
10.1 Global Immunology Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Immunology Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Immunology Drug Revenue and Market Share by Type (2013-2018)
10.2 Monoclonal Antibodies (mAb) Sales Growth and Price
10.2.1 Global Monoclonal Antibodies (mAb) Sales Growth (2013-2018)
10.2.2 Global Monoclonal Antibodies (mAb) Price (2013-2018)
10.3 Antibody Drug Conjugates Sales Growth and Price
10.3.1 Global Antibody Drug Conjugates Sales Growth (2013-2018)
10.3.2 Global Antibody Drug Conjugates Price (2013-2018)
10.4 Interferon and Cytokine therapies Sales Growth and Price
10.4.1 Global Interferon and Cytokine therapies Sales Growth (2013-2018)
10.4.2 Global Interferon and Cytokine therapies Price (2013-2018)
10.5 Immunosuppressive medication Sales Growth and Price
10.5.1 Global Immunosuppressive medication Sales Growth (2013-2018)
10.5.2 Global Immunosuppressive medication Price (2013-2018)
11 Global Immunology Drug Market Segment by Application
11.1 Global Immunology Drug Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
11.4 Cancer Research Centers and Institutes Sales Growth (2013-2018)
12 Immunology Drug Market Forecast (2018-2023)
12.1 Global Immunology Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Immunology Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Immunology Drug Market Forecast (2018-2023)
12.2.2 Europe Immunology Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Immunology Drug Market Forecast (2018-2023)
12.2.4 South America Immunology Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Immunology Drug Market Forecast (2018-2023)
12.3 Immunology Drug Market Forecast by Type (2018-2023)
12.3.1 Global Immunology Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Immunology Drug Market Share Forecast by Type (2018-2023)
12.4 Immunology Drug Market Forecast by Application (2018-2023)
12.4.1 Global Immunology Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Immunology Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Immunology Drug Picture
Table Product Specifications of Immunology Drug
Figure Global Sales Market Share of Immunology Drug by Types in 2017
Table Immun
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
